Abstract
In patients with Cerebral Venous Thrombosis (CVT), inherited and acquired thrombophilic conditions have been studied either individually or as subset of a comprehensive evaluation. None of the studies have included a comprehensive evaluation of all the known associations. The associations for various conditions have been found to differ significantly between the Indian and the Western population. We defined a Comprehensive Thrombophilia panel (inherited and acquired) comprising of 13 thrombophilic conditions to include all the relevant known associations in CVT. All patients in this cross-sectional study were evaluated as per the defined protocol during the three-year study period. We evaluated 42 patients of CVT for presence of inherited and acquired thrombophilic conditions. The mean age of the study population was 38.4 yrs. An inherited or an acquired thrombophilic condition was diagnosed in 76% patients. Hyperhomocysteinemia and raised factor VIII levels were the most common conditions, seen in 38% and 35.7% patients respectively. MTHFR mutation was seen in 21% patients. Protein S deficiency was seen in 7% patients. Factor V Leiden and JAK2 positive MPN were seen in 2.3% cases. We did not detect any patients with Protein C deficiency, APLA syndrome, anti-thrombin deficiency, PG20210A mutation or PNH. PAI-1 polymorphism was not included in the protocol as its role is controversial and it has not been established in Indian studies. There is an urgent need for Comprehensive Thrombophilia testing in a larger population of CVT patients to better delineate the spectrum of associated thrombophilic conditions. Such a study is bound to impact therapy and prognosis of CVT.
Similar content being viewed by others
References
Lauw MN, Barco S et al (2013) Cerebral venous thrombosis and thrombophilia: a systematic review and meta-analysis. Semin Thromb Hemost 39(8):913–927
Dash D, Prasad K, Joseph L (2015) Cerebral venous thrombosis: an Indian perspective. Neurol India 63(3):318–328
Ferro JM, Canhão P et al (2004) Prognosis of cerebral vein and dural sinus thrombosis. Stroke 35:664–670
Pai N, Ghosh K, Shetty S (2013) Hereditary thrombophilia in cerebral venous thrombosis: a study from India. Blood Coagul Fibrinolysis 24:540–543
Narayan D, Subhash K, Ravishankar K et al (2012) Risk factors, clinical profile, and long- term outcome of 428 patients of cerebral sinus venous thrombosis: Insights from Nizam’s Institute Venous Stroke Registry, Hyderabad (India). Neurol India 60(2):154–159
Silvis SM, de Diana Aguiar S et al (2017) Cerebral venous thrombosis. Nat Rev Neurol 13:555–565
Dentali F, Gianni M et al (2006) Natural history of cerebral vein thrombosis: a systematic review. Blood 108(4):1129–1134
Baglin T, Gray E, Greaves M et al (2010) Clinical guidelines for testing for heritable thrombophilia. Br J Haematol 149:209–220
Abbattista M, Capecchi M, Martinelli I (2020) Treatment of unusual thrombotic manifestations. Blood 135(5):326–334
Dentali F, Crowther M, Ageno W (2006) Thrombophilic abnormalities, oral contraceptives, and risk of cerebral vein thrombosis: a meta-analysis. Blood 107(7):2766–2773
Lussana F, Dentali F et al (2007) Venous thrombosis at unusual sites and the role of thrombophilia. Semin Thromb Hemost 33(6):582–587
Martinelli I, Battaglioli T, Pedotti P et al (2003) Hyperhomocysteinemia in cerebral vein thrombosis. Blood 102(4):1363–1366
Fay WP (2012) Homocysteine and thrombosis: guilt by association? Blood 119(13):2977–2978
Ospina-Romero M, Cannegieter SC et al (2018) Hyperhomocysteinemia and risk of first venous thrombosis: the influence of (Unmeasured) confounding factors. Am J Epidemiol 187(7):1392–1400
Den Heijer M, Lewington S, Clarke R (2005) Homocysteine, MTHFR and risk of venous thrombosis: a meta-analysis of published epidemiological studies. J Thromb Haemost 3(2):292–299
Ray JG (1998) Meta-analysis of hyperhomocysteinemia as a risk factor for venous thromboembolic disease. Arch Intern Med 158(19):2101–2106
Den Heijer M, Rosendaal FR, Blom HJ et al (1998) Hyperhomocysteinemia and venous thrombosis: a meta- analysis. Thromb Haemost 80(6):874–877
Gatt A, Makris M (2007) Hyperhomocysteinemia and venous thrombosis. Semin Hematol 44:70–76
Cantu C, Alonso E et al (2004) Hyperhomocysteinemia, low folate and vitamin B12 concentrations, and methylene tetrahydrofolate reductase mutation in cerebral venous thrombosis. Stroke 35:1790–1794
Martinelli I (2003) Thrombophilia testing. J Thromb Haemost 1:1311–1312
Kraaijenhagen RA, Haverkamp D, Koopman MMW et al (2000) Travel and risk of venous thrombosis. Lancet 356:1492
Salem-Berrabah OB, Fekih-Mrissa N et al (2012) Thrombophilic polymorphisms – factor V Leiden G1691A, prothrombin G20210A and MTHFR C677T – in Tunisian patients with cerebral venous thrombosis. J Clin Neurosci 19:1326–1327
Kalita J, Bansal V, Misra UK, Phadke RV (2006) Cerebral venous sinus thrombosis in a tertiary care setting in India. QJM 99(7):491–492
Meppiel E, Crassard I et al (2015) cerebral venous thrombosis in paroxysmal nocturnal hemoglobinuria. Medicine 94(1):e362
Anadure RK, Nagaraja D, Christopher R et al (2014) Plasma factor VIII in non-puerperal cerebral venous thrombosis: a prospective case–control study. J Neurol Sci 339:140–143
Vecht L, Zuurbier SM et al (2018) Elevated factor VIII increases the risk of cerebral venous thrombosis: a case–control study. J Nuerol 265(7):1612–1617
Lamy M, Palazzo P et al (2017) Should we screen for janus kinase 2 V617F mutation in cerebral venous thrombosis? Cerebrovasc Dis 44:97–104
Godenechea G, Gaillard N et al (2010) JAK2V617F mutation associated with cerebral venous thrombosis: a report of five cases. Cerebrovasc Dis 29:206–209
Passamonti SM, Biguzzi E et al (2012) The JAK2 V617F mutation in patients with cerebral venous thrombosis. J Thromb Haemost 10:998–1003
Prabhudesai A, Shetty S et al (2017) Investigation of plasminogen activator inhibitor-1 (PAI-1) 4G/5G promoter polymorphism in Indian venous thrombosis patients: a case- control study. Eur J Haematol 99(3):249–254
Funding
No financial support was received from any source for this study.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflicts of interest.
Ethical Approval
Ethical clearance was obtained for the study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Kumar, R., Vinny, P.W., Nair, V.G. et al. Comprehensive Thrombophilia Evaluation in Cerebral Venous Thrombosis: A Single Center Cross Sectional Study. Indian J Hematol Blood Transfus 38, 522–528 (2022). https://doi.org/10.1007/s12288-021-01480-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12288-021-01480-3